<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04514770</url>
  </required_header>
  <id_info>
    <org_study_id>11/2019 OBSGN 27</org_study_id>
    <nct_id>NCT04514770</nct_id>
  </id_info>
  <brief_title>Impact of Early Versus Late Amniotomy on Labour Induction in Nulliparous Women After Vaginal Misoprostol</brief_title>
  <acronym>RCT</acronym>
  <official_title>Early Versus Late Amniotomy on Labour Induction in Nulliparous Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Menoufia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Menoufia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation the effect of timing of amniotomy (early versus delayed) after vaginal&#xD;
      misoprostol in induced labor.&#xD;
&#xD;
      Condition: induction of labour intervention: eary versus late amniotomy on labour induction&#xD;
      after vaginal misoprostol Phase: Not applicable&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      study type: randomized clinical trial actual enrollment: 140 allocation: Random intervention&#xD;
      model: two groups assignment masking: open lebal primary purpose: induction of labour actual&#xD;
      study start: May 3, 2019 Primary Completion: January 10, 2020 actual study completion date:&#xD;
      March 20, 2020&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 3, 2019</start_date>
  <completion_date type="Actual">March 20, 2020</completion_date>
  <primary_completion_date type="Actual">January 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group A: Early amniotomy was performed for the participant of the first group at 3 cm cervical dilatation with Kocher's forceps provided the head is well fitted to the cervix. Group B: late amniotomy was performed for the participant of the second group at 7 cm cervical dilatation.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>successful induction</measure>
    <time_frame>immediately after intervention</time_frame>
    <description>definition of successful induction is occurrence of vaginal delivery within 24 hours from the beginning of induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>induction-delivery interval</measure>
    <time_frame>immediately after intervention</time_frame>
    <description>duration of labor and amniotomy delivery interval</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>misoprostol doses administered</measure>
    <time_frame>during the intervention</time_frame>
    <description>number of misoprostol doses administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the need for augmentation of labor</measure>
    <time_frame>during the intervention</time_frame>
    <description>the need for augmentation of labor by oxytocin and perinatal outcomes included cord prolapse and abnormal FHR changes during labor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intrapartum meconium</measure>
    <time_frame>during the intervention</time_frame>
    <description>intrapartum meconium passage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apgar score</measure>
    <time_frame>during the intervention</time_frame>
    <description>Apgar score less than 7 at 1 and 5 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>newborn admission in the neonatal intensive care unit</measure>
    <time_frame>immediately after intervention</time_frame>
    <description>newborn admission in the neonatal intensive care unit (NICU).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Labour Induction</condition>
  <arm_group>
    <arm_group_label>early amniotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group A:&#xD;
Pregnant women had taken misoprostol (vagiprost vaginal tablet; Adwia Pharmaceutical Company) vaginally as 25 micro gram of misoprostol. It was repeated every 6 hours until three or more uterine contractions of 40 second duration occur over 10 minutes, or when reaching four doses maximum (i.e. 100 micro gram) is reached.&#xD;
Early amniotomy was performed for the participant of the first group at 3 cementer cervical dilatation with Kocher's forceps provided the head is well fitted to the cervix.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late amniotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B:&#xD;
Pregnant women had taken misoprostol (vagiprost vaginal tablet; Adwia Pharmaceutical Company) vaginally as 25 micro gram of misoprostol. It was repeated every 6 hours until three or more uterine contractions of 40 second duration occur over 10 minutes, or when reaching four doses maximum (i.e. 100 micro gram) is reached.&#xD;
late amniotomy was performed for the participant of the second group at 7 cementer cervical dilatation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>rupture of membrane early and late</description>
    <arm_group_label>Late amniotomy</arm_group_label>
    <arm_group_label>early amniotomy</arm_group_label>
    <other_name>Amniotomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Pregnant women at 36 weeks gestation or more&#xD;
&#xD;
          2. Nullipara&#xD;
&#xD;
          3. singleton fetus&#xD;
&#xD;
          4. cephalic presentation with common medical causes for labour induction e.g.&#xD;
             intrauterine fetal growth restriction, post term pregnancy and preeclampsia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Macrocosmic babies with estimated fetal weight of more than 4000 gram&#xD;
&#xD;
          2. Previous uterine scars&#xD;
&#xD;
          3. Pre labor premature rupture of fetal membranes&#xD;
&#xD;
          4. Polyhydramnios.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Nulliparous Women</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Menoufia University hospital</name>
      <address>
        <city>ShibÄ«n Al Kawm</city>
        <state>Menoufia</state>
        <zip>11111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 28, 2020</study_first_submitted>
  <study_first_submitted_qc>August 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2020</study_first_posted>
  <last_update_submitted>August 12, 2020</last_update_submitted>
  <last_update_submitted_qc>August 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Menoufia Obstetrics and Gynecology Group</investigator_affiliation>
    <investigator_full_name>Mohamed Elsibai Anter</investigator_full_name>
    <investigator_title>Lecturer of obstetrics and gynecology</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

